Earnings summaries and quarterly performance for SCOTTS MIRACLE-GRO.
Research analysts who have asked questions during SCOTTS MIRACLE-GRO earnings calls.
Eric Bosshard
Cleveland Research Company
4 questions for SMG
Jon Andersen
William Blair & Company
4 questions for SMG
Jonathan Matuszewski
Jefferies Financial Group Inc.
4 questions for SMG
Peter Grom
UBS Group
4 questions for SMG
W. Andrew Carter
Stifel
4 questions for SMG
Christopher Carey
Wells Fargo & Company
3 questions for SMG
Joseph Altobello
Raymond James & Associates, Inc.
3 questions for SMG
William Reuter
Bank of America
3 questions for SMG
Carla Casella
JPMorgan Chase & Co.
2 questions for SMG
Chris Carey
Wells Fargo Securities
2 questions for SMG
Joseph Altobelle
Raymond James
1 question for SMG
Martin Mitela
Raymond James & Associates, Inc.
1 question for SMG
William Carter
Stifel Financial Corp
1 question for SMG
William Chappell
Truist Securities
1 question for SMG
Recent press releases and 8-K filings for SMG.
- For Q1 2026 (three months ended December 27, 2025), SMG reported an Adjusted Gross Margin Rate of 25.4% and Adjusted EBITDA of $3.0 million, with an Adjusted Diluted Net Loss per common share from continuing operations of $(0.77).
- The company provided Fiscal 2026 guidance, targeting an Adjusted Gross Margin Rate of at least 32%, Adjusted EPS from Continuing Operations between $4.15 and $4.35 per share, and $275 million in Free Cash Flow.
- SMG reclassified its Hawthorne business as a discontinued operation in Q1 2026, which resulted in a $77.2 million loss from discontinued operations, net of tax.
- The company aims to achieve a leverage ratio in the high 3's by the end of FY26 and has authorized a share repurchase program.
- Scotts Miracle-Gro reported Q1 2026 net sales of $354.4 million and a non-GAAP adjusted loss of $0.77 per share, while improving its non-GAAP adjusted gross margin rate to 25.4% and reducing its net debt to adjusted EBITDA leverage ratio to 4.03 times.
- The company reaffirmed its fiscal 2026 guidance, including low single-digit US consumer net sales growth and non-GAAP adjusted EPS of $4.15-$4.35, with management expressing confidence in potentially outperforming these targets.
- A new multi-year $500 million share repurchase program was approved, slated to begin later in 2026, with the ultimate goal of reducing the share count to approximately 40 million shares.
- Scotts Miracle-Gro outlined long-term financial priorities through 2030, targeting an incremental $1 billion in top-line sales and $1 billion in total EBITDA, driven by a 5% annual top-line growth strategy.
- The Hawthorne business was classified as a discontinued operation in Q1 2026, leading to a $105 million pre-tax asset impairment charge, as part of a transaction where Vireo Growth will acquire Hawthorne.
- Scotts Miracle-Gro (SMG) reported Q1 2026 total company net sales of $354.4 million (excluding Hawthorne) and a non-GAAP adjusted loss of $0.77 per share, while reducing its net debt to adjusted EBITDA leverage ratio to 4.03 times.
- The company reaffirmed its fiscal 2026 guidance, projecting non-GAAP adjusted EPS of $4.15-$4.35 and $275 million in free cash flow, aiming for a leverage ratio in the high threes.
- A new multi-year, $500 million share repurchase program was approved, scheduled to begin later in 2026, with a long-term objective to reduce the share count to approximately 40 million shares.
- SMG set new long-term financial priorities through 2030, targeting an incremental $1 billion in top-line sales and $1 billion in total EBITDA, driven by 5% annual top-line growth.
- The pending divestiture of Hawthorne, now classified as a discontinued operation, led to a $105 million pre-tax asset impairment charge.
- Scotts Miracle-Gro (SMG) reported Q1 2026 results, with total company net sales of $354.4 million and a non-GAAP adjusted loss of $0.77 per share.
- The company initiated a new multi-year, $500 million share repurchase program set to begin later in 2026, with a long-term goal to reduce the share count to approximately 40 million shares.
- SMG is divesting its Hawthorne business, which is now classified as a discontinued operation and resulted in a $105 million pre-tax asset impairment charge in Q1 2026. This divestiture is expected to contribute to a 40 basis point improvement in gross margin.
- New longer-term financial priorities through 2030 target $1 billion in incremental top-line sales and $1 billion in total EBITDA, aiming for 5% annual top-line growth.
- The company reaffirmed its fiscal 2026 guidance, projecting low single-digit US consumer net sales growth, a non-GAAP adjusted gross margin rate of at least 32%, and non-GAAP adjusted earnings from continuing operations per share of $4.15-$4.35.
- ScottsMiracle-Gro reported Q1 2026 results, with U.S. Consumer net sales of $328.5 million and a non-GAAP adjusted net loss from continuing operations of $0.77 per share, an improvement of $0.11 per share over the prior year.
- The company announced a divestiture plan for its Hawthorne subsidiary to Vireo Growth, Inc., with closing anticipated in fiscal Q2 2026, and has classified Hawthorne as a discontinued operation.
- A new multi-year share repurchase program was approved, authorizing the repurchase of up to $500 million of common stock, set to begin in late 2026.
- ScottsMiracle-Gro reaffirmed its fiscal 2026 guidance, projecting low single-digit growth for U.S. Consumer net sales and non-GAAP adjusted net income per share from continuing operations of $4.15 to $4.35.
- ScottsMiracle-Gro reported a net loss of $(125.0) million and diluted net loss per common share of $(2.16) for the first quarter ended December 27, 2025, with U.S. Consumer net sales of $328.5 million and non-GAAP adjusted EBITDA of $3.0 million.
- The company is in advanced discussions to divest its Hawthorne subsidiary to Vireo Growth, Inc., with an anticipated closing in the fiscal second quarter, and has reclassified Hawthorne as a discontinued operation.
- A new multi-year share repurchase program authorizing up to $500 million of common stock was approved, with repurchases expected to commence in late 2026.
- ScottsMiracle-Gro reaffirmed its fiscal 2026 guidance, projecting low single-digit growth for U.S. Consumer net sales and non-GAAP adjusted net income per share from continuing operations between $4.15 and $4.35.
- The Scotts Miracle-Gro Company has focused on improving its capital structure, paying down over $1.5 billion in debt and significantly improving leverage, with a goal to return to historic norms (leverage in the threes) later in fiscal year 2026.
- Management reported consistent improvements in performance, including significant free cash flow generation, meaningful margin improvement, and solid EBITDA growth, driven by investments in brand, innovation, e-commerce, and operational efficiencies through automation and AI.
- Shareholders approved key proposals, including the election of four directors, an advisory vote on executive compensation, the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2026, and an amendment to the long-term incentive plan to increase common shares available for grant.
- The company expressed an optimistic view for Fiscal 2026 and beyond, with its incentive structure aligned with the successful execution of its Fiscal 2026 operating plan.
- The Scotts Miracle-Gro Company has focused on improving its capital structure, paying down over $1.5 billion in debt and expecting leverage to return to historic norms in the threes later in fiscal year 2026, while also achieving significant free cash flow generation, meaningful margin improvement, and solid EBITDA growth.
- The company is investing in its brand and business, driving growth in e-commerce and digital spaces, and implementing automation and AI for cost efficiencies and supply chain optimization.
- Shareholders approved the election of Jim Hagedorn, Edith Avilés, Rob Candelino, and Mark Kingdon as directors, the advisory vote on executive compensation, the ratification of Deloitte & Touche LLP as the independent auditor for fiscal year 2026, and an amendment to the long-term incentive plan to increase common shares available for grant.
- The Scotts Miracle-Gro Company has paid down over $1.5 billion in debt and expects to return to historic leverage norms (in the threes) later in Fiscal Year 2026, demonstrating significant improvement in its capital structure and financial performance.
- The company is strategically focused on investing in its brand and innovation, driving growth in e-commerce and digital, and achieving cost efficiencies through automation and AI.
- During the annual meeting, shareholders elected four directors (Jim Hagedorn, Edith Avilés, Rob Candelino, and Mark Kingdon), approved on an advisory basis the compensation of named executive officers, ratified Deloitte & Touche LLP as the independent registered public accounting firm for FY 2026, and approved an amendment and restatement of the long-term incentive plan.
- Scotts Miracle-Gro (SMG) supports President Trump's executive order to reschedule cannabis from a Schedule I to a Schedule III drug, a move CEO Jim Hagedorn called "long overdue".
- The rescheduling will remove the 280E tax penalty for cannabis companies, which previously resulted in tax rates of 70% or higher, allowing them to shift financial resources into capital investment and growth opportunities.
- This change is expected to positively impact SMG's Hawthorne Gardening Company subsidiary, which provides supplies to legal cannabis operations, as increased capital spending by cannabis companies could follow.
- ScottsMiracle-Gro plans to combine Hawthorne with a cannabis company early in fiscal 2026 as part of its strategy to focus Hawthorne as a cannabis-dedicated entity, with the reclassification making it a more attractive partner.
Fintool News
In-depth analysis and coverage of SCOTTS MIRACLE-GRO.
Quarterly earnings call transcripts for SCOTTS MIRACLE-GRO.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more

